!ID 0000001
!v001!001132
!v002!56
!ID 0000002
!v001!001138
!v002!62
!ID 0000003
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!5
!v701!1
!v709!article
!v708!78
!v704!<p><a name="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Infec&ccedil;&atilde;o    pelo v&iacute;rus da hepatite C em gestantes em Mato Grosso do Sul, 2005-2007</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000004
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!6
!v701!2
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000005
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!7
!v701!3
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Infecci&oacute;n    por el virus de la hepatitis C en gestantes en Mato Grosso do Sul, Centro-Oeste    de Brasil, 2005-2007</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000006
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!8
!v701!4
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000007
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!9
!v701!5
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000008
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!10
!v701!6
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Clarice Souza    Pinto<sup>I</sup>; Regina Maria Bringel Martins<sup>II</sup>; Sonia Maria Oliveira    de Andrade<sup>III</sup>; Alcione Cavalheiro Faro Stief<sup>III</sup>; Roberto    Dias de Oliveira<sup>IV</sup>; Ana Rita Coimbra Motta de Castro<sup>III</sup></b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000009
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!11
!v701!7
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Programa    Estadual de DST/Aids e Hepatites Virais. Secretaria de Estado de Sa&uacute;de    de Mato Grosso do Sul. Campo Grande, MS, Brasil    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000010
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!12
!v701!8
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>II</sup>Instituto    de Patologia Tropical e Sa&uacute;de P&uacute;blica. Universidade Federal de    Goi&aacute;s. Goi&acirc;nia, GO, Brasil    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000011
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!13
!v701!9
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>III</sup>Departamento    de Farm&aacute;cia Bioqu&iacute;mica. Centro de Ci&ecirc;ncias Biol&oacute;gicas    e da Sa&uacute;de. Universidade Federal de Mato Grosso do Sul. Campo Grande,    MS, Brasil    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000012
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!14
!v701!10
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>IV</sup>Curso    de Enfermagem. Universidade Estadual de Mato Grosso do Sul. Dourados, MS, Brasil</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000013
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!15
!v701!11
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Correspond&ecirc;ncia</a></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000014
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!16
!v701!12
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000015
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!17
!v701!13
!v709!article
!v708!78
!v704!<p>&nbsp;</p> <hr size="1" noshade>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000016
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!18
!v701!14
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000017
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!19
!v701!15
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">O estudo teve por    objetivo estimar a preval&ecirc;ncia da infec&ccedil;&atilde;o e gen&oacute;tipo    do v&iacute;rus da hepatite C (HCV), bem como determinar a subnotifica&ccedil;&atilde;o    de casos. O total de 115.386 gestantes atendidas pelo Programa Estadual de Prote&ccedil;&atilde;o    &agrave; Gestante de Mato Grosso do Sul foi submetido &agrave; coleta de sangue    para a detec&ccedil;&atilde;o de anti-HCV, de 2005 a 2007. A preval&ecirc;ncia    da infec&ccedil;&atilde;o pelo HCV foi de 1,07 casos/1.000. As amostras positivas    foram submetidas &agrave; detec&ccedil;&atilde;o do HCV-RNA e genotipadas. O    gen&oacute;tipo 1 foi encontrado em 73% das amostras, 24,3% pertenciam ao gen&oacute;tipo    3 e 2,7% ao gen&oacute;tipo 2. A subnotifica&ccedil;&atilde;o de casos de hepatite    C foi de 35,5%..</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000018
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!20
!v701!16
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Descritores:    </b> Gestantes. Hepatite C, epidemiologia. Hepaciv&iacute;rus, gen&eacute;tica.    Estudos Soroepidemiol&oacute;gicos.</font></p> <hr size="1" noshade>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000019
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!21
!v701!17
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMEN</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000020
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!22
!v701!18
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">El estudio tuvo    por objetivo estimar la prevalencia de la infecci&oacute;n y genotipo del virus    de la hepatitis C (HCV), as&iacute; como determinar la subnotificaci&oacute;n    de casos. El total de 115.386 gestantes atendidas por el Programa Estatal de    Protecci&oacute;n a la Gestante de Mato Grosso do Sul (Centro-Oeste de Brasil)    fueron sometidas a la colecta de sangre para la detecci&oacute;n de anti-HCV,    de 2005 a 2007. La prevalencia de la infecci&oacute;n por el HCV fue de 1,07    casos/1000. Las muestras positivas fueron sometidas a la detecci&oacute;n del    HCV-RNA y genotipadas. El genotipo 1 fue encontrado en 73% de las muestras,    24,3% pertenec&iacute;an al genotipo 3 y 2,7% al genotipo 2. La subnotificaci&oacute;n    de casos de hepatitis C fue de 35,5%.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000021
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!23
!v701!19
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Descriptores:    </b> Mujeres Embarazadas. Hepatitis C, epidemiolog&iacute;a. Hepacivirus, gen&eacute;tica.    Estudios Seroepidemiol&oacute;gicos.</font></p> <hr size="1" noshade>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000022
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!24
!v701!20
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000023
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!25
!v701!21
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000024
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!26
!v701!22
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>INTRODU&Ccedil;&Atilde;O</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000025
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!27
!v701!23
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Globalmente, o    v&iacute;rus da hepatite C (HCV) infecta 130 milh&otilde;es de pessoas e a maioria    delas &eacute; portadora cr&ocirc;nica. A hepatite C constitui um importante    problema de sa&uacute;de p&uacute;blica na atualidade, pois 50% a 85% dos casos    evoluem para cronicidade, podendo levar ao desenvolvimento de cirrose e carcinoma    hepatocelular.<sup>1</sup></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000026
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!28
!v701!24
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">O HCV possui seis    gen&oacute;tipos (1-6) e m&uacute;ltiplos subtipos que apresentam distribui&ccedil;&atilde;o    geogr&aacute;fica vari&aacute;vel. Os gen&oacute;tipos 1, 2 e 3 apresentam uma    distribui&ccedil;&atilde;o mundial. Os subtipos 1a, 1b, 2a, 2b e 3a s&atilde;o    encontrados no Brasil, Europa Ocidental e Estados Unidos. Na &Iacute;ndia, Bangladesh    e outras partes da &Aacute;sia, o gen&oacute;tipo 3 &eacute; o mais comum. No    norte da &Aacute;frica e no Oriente M&eacute;dio, particularmente no Egito,    predomina o gen&oacute;tipo 4. Os gen&oacute;tipos 5 e 6 s&atilde;o encontrados    em regi&otilde;es geogr&aacute;ficas espec&iacute;ficas, como &Aacute;frica    do Sul e &Aacute;sia, respectivamente.<sup>1,2</sup></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000027
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!29
!v701!25
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">No Brasil, a preval&ecirc;ncia    da infec&ccedil;&atilde;o pelo HCV nas gestantes n&atilde;o parece diferir daquela    encontrada na popula&ccedil;&atilde;o geral, variando entre 0,9% e 1,5%. Apesar    do risco relativamente baixo de transmiss&atilde;o vertical, a falta de propostas    profil&aacute;ticas espec&iacute;ficas justifica a realiza&ccedil;&atilde;o    da triagem para hepatite C de rotina em gestantes.<sup>3</sup></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000028
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!30
!v701!26
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">O presente estudo    teve como objetivo estimar a preval&ecirc;ncia da infec&ccedil;&atilde;o pelo    HCV entre as gestantes, identificar os principais gen&oacute;tipos e subtipos    virais circulantes, bem como estimar a subnotifica&ccedil;&atilde;o dos casos    de hepatite C.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000029
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!31
!v701!27
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000030
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!32
!v701!28
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>M&Eacute;TODOS</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000031
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!33
!v701!29
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Estudo descritivo    transversal, retrospectivo, realizado com 115.386 gestantes atendidas pelo Programa    Estadual de Prote&ccedil;&atilde;o &agrave; Gestante de Mato Grosso do Sul,    no per&iacute;odo de janeiro de 2005 a dezembro de 2007. Esse total representa    97% das gestantes de Mato Grosso do Sul, considerando-se como refer&ecirc;ncia    o total de nascidos vivos. As gestantes inclu&iacute;das fizeram a primeira    avalia&ccedil;&atilde;o sorol&oacute;gica do pr&eacute;-natal no Instituto de    Pesquisa, Ensino e Diagn&oacute;stico - Associa&ccedil;&atilde;o dos Pais e    Amigos dos Excepcionais (Iped-Apae).</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000032
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!34
!v701!30
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">As amostras de    sangue foram coletadas em unidades de sa&uacute;de de todos os munic&iacute;pios    do Estado por pun&ccedil;&atilde;o digital em papel de filtro previamente identificado.    Todas as amostras foram testadas para detec&ccedil;&atilde;o de anticorpos para    o v&iacute;rus da hepatite C (anti-HCV) por ensaio imunoenzim&aacute;tico (ELISA).    As gestantes cuja amostra se apresentou positiva ou indeterminada foram submetidas    a uma nova coleta por pun&ccedil;&atilde;o venosa para a realiza&ccedil;&atilde;o    de testes moleculares. As amostras anti-HCV positivas foram testadas para detec&ccedil;&atilde;o    do RNA viral pela rea&ccedil;&atilde;o em cadeia da polimerase em tempo real    (<i>Real Time</i> PCR) utilizando-se <i>primers</i> complementares &agrave;    regi&atilde;o 5' n&atilde;o codificante do genoma do HCV. As amostras RNA-HCV    positivas foram submetidas &agrave; genotipagem pelo m&eacute;todo <i>line probe    assay</i> (INNO-LiPA, Versant HCV Genotype Assay, Innogenetics, B&eacute;lgica),    empregando-se <i>primers</i> biotinilados complementares &agrave; regi&atilde;o    5' n&atilde;o codificante do genoma do HCV.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000033
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!35
!v701!31
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Outras infec&ccedil;&otilde;es,    como s&iacute;filis, toxoplasmose, hepatite B, infec&ccedil;&atilde;o pelo HIV,    infec&ccedil;&atilde;o pelo v&iacute;rus da leucemia da c&eacute;lula T humana    (HTLV), herpes simples, citomegalov&iacute;rus, rub&eacute;ola, clam&iacute;dia    e doen&ccedil;a de chagas, foram investigadas concomitantemente ao anti-HCV.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000034
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!36
!v701!32
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Os casos de gestantes    anti-HCV positivas pelos exames de triagem do Iped/Apae foram comparados aos    notificados no banco de dados do Sistema de Informa&ccedil;&atilde;o de Agravos    de Notifica&ccedil;&atilde;o (Sinan), buscando estimar a subnotifica&ccedil;&atilde;o    de casos de hepatite C.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000035
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!37
!v701!33
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Os dados foram    analisados pelos programas: EpiInfo 3.4.1 e SPSS vers&atilde;o 13.0. Para compara&ccedil;&atilde;o    de preval&ecirc;ncias calculadas foram utilizados o teste de qui-quadrado, e    o n&iacute;vel de signific&acirc;ncia foi estabelecido como p &lt; 0,05.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000036
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!38
!v701!34
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">O estudo foi aprovado    pelo Comit&ecirc; de &Eacute;tica em Pesquisa Envolvendo Seres Humanos da Universidade    Federal de Mato Grosso do Sul (CEP/UFMS protocolo n&#186; 488/2009).</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000037
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!39
!v701!35
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000038
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!40
!v701!36
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>RESULTADOS</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000039
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!41
!v701!37
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Das gestantes,    124 foram positivas para o anti-HCV, uma taxa de preval&ecirc;ncia de 1,07 casos/1.000    (<a href="#t1">Tabela</a>). As taxas de preval&ecirc;ncia n&atilde;o se mostraram    distribu&iacute;das uniformemente dentro do estado, variando de 0,45/1.000 no    munic&iacute;pio de Nova Andradina a 6,25/1.000 em Novo Horizonte do Sul. Os    munic&iacute;pios com as maiores taxas de preval&ecirc;ncia para o marcador    anti-HCV est&atilde;o localizados no centro-sul do estado e possuem menos de    10.000 habitantes.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000040
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!42
!v701!38
!v709!article
!v708!78
!v704!<p><a name="t1"></a></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000041
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!43
!v701!39
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000042
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!44
!v701!40
!v709!article
!v708!78
!v704!<p align="center"><img src="/img/revistas/rsp/2011nahead/2493t01.jpg" width="380" height="484"></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000043
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!45
!v701!41
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000044
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!46
!v701!42
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Observou-se tend&ecirc;ncia    crescente conforme o aumento da idade (p &lt; 0,001). Mais da metade das gestantes    estudadas (54,8%) tinham entre 20 e 29 anos, uma preval&ecirc;ncia de anti-HCV    de 1,05/1.000. Na faixa et&aacute;ria de 30 a 39 anos a preval&ecirc;ncia foi    de 1,94/1.000 e na faixa et&aacute;ria de 40-49 anos foi de 2,79/1.000.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000045
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!47
!v701!43
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A maioria das gestantes    (53,2%) positivas para anti-HCV foi submetida &agrave; triagem pr&eacute;-natal    no primeiro trimestre de gesta&ccedil;&atilde;o, 28,22% no segundo trimestre    e 5,6% no terceiro trimestre. Em 12,9% das gestantes, essa informa&ccedil;&atilde;o    estava indispon&iacute;vel.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000046
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!48
!v701!44
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Das 124 amostras    soropositivas para anti-HCV, 81 (65,3%) foram positivas para a regi&atilde;o    5' n&atilde;o codificante. Dessas, 74 (91,3%) foram genotipadas, sendo o gen&oacute;tipo    1 (73,3%) predominante, seguido pelos gen&oacute;tipos 3 (24,3%) e 2 (2,7%).    Dentre as 46 (62,2%) amostras subtipadas, 75,1% pertenciam ao subtipo 1a (25/33),    21,2% ao 1b (7/33) e 3% ao 1d (1/33); o subtipo 2a foi encontrado em apenas    uma amostra; 91,7% (11/12) pertenciam ao subtipo 3a; e 8,3% (1/12) foram classificadas    como 3d.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000047
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!49
!v701!45
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Em 13,7% dos casos    de infec&ccedil;&atilde;o pelo HCV observaram-se co-infec&ccedil;&otilde;es,    a mais prevalente tendo sido s&iacute;filis (8,1%), seguida pelo HIV (2,5%).    A subnotifica&ccedil;&atilde;o da hepatite C no Sinan foi de 35,5%, variando    de 23,1% no ano de 2007 a 40,3% no ano de 2006.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000048
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!50
!v701!46
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000049
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!51
!v701!47
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>DISCUSS&Atilde;O</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000050
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!52
!v701!48
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">O presente estudo    constitui a primeira investiga&ccedil;&atilde;o epidemiol&oacute;gica da infec&ccedil;&atilde;o    pelo HCV em gestantes do Mato Grosso do Sul, incluindo a genotipagem viral.    A preval&ecirc;ncia global do marcador anti-HCV foi de 1,07 (casos/1.000), similar    &agrave;s estimativas calculadas para gestantes de tr&ecirc;s munic&iacute;pios    de Goi&aacute;s (1,50 casos/1.000).<sup>3</sup> Por outro lado, a preval&ecirc;ncia    encontrada no presente estudo foi inferior &agrave; encontrada em indiv&iacute;duos    com idade acima de 19 anos em um inqu&eacute;rito de base populacional no Centro-Oeste    (19,0 (casos/1.000).<sup>5</sup></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000051
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!53
!v701!49
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Assim como em outro    estudo realizado no Centro-Oeste,<sup>3</sup> a preval&ecirc;ncia do HCV na    popula&ccedil;&atilde;o de gestantes estudadas apresentou tend&ecirc;ncia crescente    com o aumento da idade, e a maior preval&ecirc;ncia encontrada foi na faixa    et&aacute;ria de 40 a 49 anos (2,79/1.000).</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000052
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!54
!v701!50
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A genotipagem revelou    a predomin&acirc;ncia do gen&oacute;tipo 1, seguido pelos 3 e 2, e a subtipagem    do subtipo 1a (54,3%), seguido do 3a (23,9%). Esses resultados est&atilde;o    em conformidade com os achados de estudo sobre a distribui&ccedil;&atilde;o    geogr&aacute;fica dos gen&oacute;tipos do HCV no Brasil.<sup>2</sup></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000053
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!55
!v701!51
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A co-infec&ccedil;&atilde;o    com o HIV foi observada em 2,5% dos casos, abaixo do &iacute;ndice mundial de    at&eacute; 6,5%.<sup>4</sup></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000054
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!56
!v701!52
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A subnotifica&ccedil;&atilde;o    de 35,5% encontrada no presente trabalho denota falhas na rotina dos servi&ccedil;os    de vigil&acirc;ncia da hepatite C e dificulta a&ccedil;&otilde;es de planejamento    e controle do agravo.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000055
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!57
!v701!53
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A baixa preval&ecirc;ncia    (1,07 casos/1.000) da infec&ccedil;&atilde;o pelo HCV encontrada nas gestantes    estudadas n&atilde;o descarta a possibilidade da ocorr&ecirc;ncia de transmiss&atilde;o    vertical, devendo ser monitorada por meio da triagem realizada no pr&eacute;-natal.    Al&eacute;m disso, a elevada taxa de subnotifica&ccedil;&atilde;o da hepatite    C sugere baixa sensibilidade da vigil&acirc;ncia, a qual deve ser prontamente    corrigida, visando &agrave; melhor fundamenta&ccedil;&atilde;o dos programas    de preven&ccedil;&atilde;o e controle da hepatite C nas gestantes de Mato Grosso    do Sul.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000056
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!58
!v701!54
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000057
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!59
!v701!55
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>REFER&Ecirc;NCIAS</b></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000058
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!60
!v701!56
!v709!article
!v708!78
!v888!1
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Alter MJ. Epidemiology    of viral hepatitis C infection. <i>World J Gastroenterol</i>. 2007;13(17):2436-41.    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000059
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!61
!v701!57
!v709!article
!v708!78
!v704!</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000060
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!62
!v701!58
!v709!article
!v708!78
!v888!2
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Campiotto S,    Pinho JRR, Carrilho FJ, Silva LC, Souto FJD, Spinelli V. Geografic distribution    of hepatitis C v&iacute;rus genotypes in Brazil. <i>Braz J Med Biol Res</i>.    2005;38(1):41-9. DOI:10.1590/S0100-879X2005000100007</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000061
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!63
!v701!59
!v709!article
!v708!78
!v888!3
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Costa ZB, Machado    GC, Avelino MM, Gomes Filho C, Macedo Filho JV, Minuzzi AL, et al. Prevalence    and risk factors for Hepatitis C and HIV-1 infections among pregnant women in    Central Brazil. <i>BMC Infect Dis.</i> 2009;9(116).    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000062
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!64
!v701!60
!v709!article
!v708!78
!v704!</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000063
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!65
!v701!61
!v709!article
!v708!78
!v888!4
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Laurent C, Henzel    D, Mulanga-Kabeya C, Maertens G, Larouze B, Delaporte E. Seroepidemiological    survey of hepatitis C virus among commercial sex workers and pregnant women    in Kinshasa, Democratic Republic of Congo. <i>Int J Epidemiol</i>. 2001;30(4):    872-7. DOI:10.1093/ije/30.4.872</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000064
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!66
!v701!62
!v709!article
!v708!78
!v888!5
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Turchi MD, Martelli    C, Oliveira R, Silva F, Aires R, Bariani B, et al. Population based hepatites    A,B e C sero-survey and genotypes in Central West region of Brazil. <i>Trop    Med Int Health</i>. 2007;12(Suppl 1):141.    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000065
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!67
!v701!63
!v709!article
!v708!78
!v704!</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000066
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!68
!v701!64
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000067
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!69
!v701!65
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000068
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!70
!v701!66
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a name="back"></a><a href="#top"><img src="/img/revistas/rsp/2011nahead/seta.jpg" border="0"></a>    <b> Correspond&ecirc;ncia:    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000069
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!71
!v701!67
!v709!article
!v708!78
!v704!<br>   </b> </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Clarice    Souza Pinto    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000070
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!72
!v701!68
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Rua Marqu&ecirc;s    de Lavradio, 613    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000071
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!73
!v701!69
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Bloco 5 -    Apto 12 - Jardim S&atilde;o Louren&ccedil;o    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000072
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!74
!v701!70
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">79041-911    Campo Grande, MS, Brasil    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000073
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!75
!v701!71
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">E-mail: <a href="mailto:claricepm@gmail.com">claricepm@gmail.com</a></font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000074
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!76
!v701!72
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Recebido: 6/8/2010    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000075
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!77
!v701!73
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Aprovado:    6/4/2011    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000076
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!78
!v701!74
!v709!article
!v708!78
!v704!<br>   </font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000077
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!79
!v701!75
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000078
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!80
!v701!76
!v709!article
!v708!78
!v704!<p>&nbsp;</p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000079
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!81
!v701!77
!v709!article
!v708!78
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Artigo baseado    na disserta&ccedil;&atilde;o de mestrado de Pinto CS, apresentada &agrave; Universidade    Federal de Mato Grosso do Sul em 2009.    ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
!ID 0000080
!v004!v45n5
!v702!V:\SciELO\serial\rsp\v45n5\markup\2527.htm
!v705!S
!v706!p
!v700!82
!v701!78
!v709!article
!v708!78
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Os autores    declaram n&atilde;o haver conflitos de interesses.</font></p>     ^cY
!v003!2527.htm
!v9999!../bases-work/rsp/rsp
!v936!^i0034-8910^y2011^o5
!v002!S0034-8910(11)04500519
!v882!^v45^n5
!v880!S0034-89102011000500019
